cGMP-binding, cGMP-specific phosphodiesterase, PDE5 : expression and regulation

Abstract

Regulation of PDE5 in cGMP Signaling Pathways

Abstract and Synopsis Introduction Cellular signaling involves the transmission of both intracellular and extracellular signals. Binding of a ligand to its receptor initiates a signaling cascade, relaying the signal to intracellular effectors to achieve the desired downstream effect. Second messengers such as cAMP and cGMP act as intermediates in signal transmission.

This study focuses on cGMP, synthesized by guanylyl cyclases (membrane-bound or cytosolic). The signal is terminated by phosphodiesterases (PDEs), which degrade cGMP to inactive 5 GMP. PDEs comprise 11 families classified by substrate specificity, regulation, and inhibitor sensitivity. Here, PDE5, the cGMP-binding, cGMP-specific PDE, is the molecule of interest.

GC-C Mediated Signaling

Guanylyl cyclase C (GC-C) is a membrane-associated receptor for heat-stable enterotoxins (ST) and endogenous ligands such as guanylin and uroguanylin.

In T84 colonic carcinoma cells, GC-C activation increases cGMP levels, activating protein kinases that phosphorylate CFTR, leading to ion and water secretion.

Hyperactivation by ST peptides causes excessive fluid loss, resulting in traveler’s diarrhea.

PDE5 Regulation

Prolonged ST exposure leads to receptor desensitization and PDE5 activation.

Three splice variants: PDE5A1 (longest), PDE5A2, and PDE5A3 (shortest).

PDE5 consists of an N-terminal regulatory domain (phosphorylation site, tandem GAF domains) and a C-terminal catalytic domain.

Phosphorylation and cGMP binding are prerequisites for PDE5 activation.

Experimental Findings

RT-PCR and 5 RACE confirmed presence of PDE5A1 and PDE5A2 in T84 cells.

Ribonuclase protection assays showed higher transcript levels of PDE5A1, but protein expression favored PDE5A2, suggesting translational regulation.

ST treatment correlated cGMP levels with PDE activity, without increased protein expression.

Immunoprecipitation confirmed phosphorylation of PDE5 at conserved serine residues upon ST treatment.

GAF Domain Characterization

GST-fusion proteins of PDE5 GAF domains showed a single high-affinity cGMP binding site.

Mutational analysis (Asp257, Asp446, Phe163) revealed critical roles in cGMP binding and protein folding.

GFP-fusion constructs demonstrated intracellular cGMP sequestration, forming concentrated pools that influenced other signaling processes.

Physiological Role of PDE5

PDE5 expression was highest in colon, stomach, and caecum, with appreciable levels in ileum.

Rat ileum loop experiments showed fluid accumulation upon ST or sildenafil citrate (Viagra™) treatment, confirming PDE5’s role in fluid balance regulation.

Conclusions PDE5 regulation involves complex mechanisms of cGMP binding, phosphorylation, and allosteric modulation.

GAF domains play a central role in cGMP sequestration and regulation.

PDE5 is critical in maintaining intestinal fluid balance, with direct implications for diarrheal diseases and therapeutic interventions.

This study highlights the importance of signal termination in maintaining proper cellular physiology.